Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)

Thursday, November 8, 2007

Comments

PRNewswire-FirstCall

ABBOTT PARK, Ill. A study of ankylosing spondylitis (AS) patients treated with Abbott's HUMIRA(R) showed a decrease in the rate of uveitis flares by approximately half compared to patients treated with placebo.

Full Story

If standard keratometry and biometry measurements are used to calculate the IOL power in a patient who has previously had myopic LASIK, the selected IOL power will most likely be too high.
1. True
2. False
Check The Answer

3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product
PanoCam™ LT Wide-field Digital Imaging System
The PanoCam LT represents the first ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)

Comments

Related Categories

Refractive Products and Equipment »

Glaucoma Testing Equipment / Glaucoma Products »

Cataract Products and Equipment »

Quick Quiz

If standard keratometry and biometry measurements are used to calculate the IOL power in a patient who has previously had myopic LASIK, the selected IOL power will most likely be too high.

AdGlare RMR Ad

Cataract Featured Products

3nethra classic Ophthalmic Imaging Device

PanoCam™ LT Wide-field Digital Imaging System

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us